Appears On
Episode Appearances
The Top Line · Jul 10, 2026
A $10B deal, China trial scrutiny and highlights from ADA 2026
“Hosted The Top Line episode covering Vertex deal, China trial scrutiny, and ADA 2026 highlights”
Vertex Crinetics acquisition and rare endocrine disease expansionClinical trial regulation and China data integrity scrutinyGLP-1 agonist efficacy and weight loss outcomes
View Analysis